EUVIMEDEUVIMED entdecken
Crossref

An integrated lab-in-a-tube platform for point-of-care detection of blaKPC in urinary tract infections

Shuang Yang, Yu Liu, Junheng Zhang, Jingsong Xu, Tianming Li, Haiqian Huang, Ziyue Zhu, Min Li, Hua Wang, Cuixia Yang

Microchimica Acta · 2025

DOI: 10.1007/s00604-025-07616-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, 2025. Verfasst von Shuang Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233,…. Hauptthemen laut MEDLINE: Urinary Tract Infections, Klebsiella pneumoniae, beta-Lactamases, Bacterial Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Cross-Research Fund of Biomedical Engineering of Shanghai Jiaotong University, The Clinical and Excellence Program at the Institute of Molecular Medicine, Shanghai Jiao Tong University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenem-resistant Klebsiella pneumoniae (CRKP), predominantly mediated by the blaKPC carbapenemase gene, poses a critical therapeutic challenge for urinary tract infections (UTIs). To enable rapid identification at the point of need, we engineered TubeCARE (tube-integrated platform for carbapenem antimicrobial resistance evaluation), an integrated, disposable lab-in-a-tube system for direct blaKPC detection from urine samples. This self-contained system uniquely combines urine processing, nucleic acid extraction, recombinase polymerase amplification (RPA), and CRISPR/Cas12a reaction within a single sealed unit, offering dual-modality outputs: smartphone-based real-time fluorescence or naked-eye lateral flow strip interpretation. The full workflow delivers "sample-in, result-out" in 40 min, eliminating external multi-step nucleic acid extraction and reducing contamination risks. Both detection modes demonstrated laboratory-grade sensitivity (1 CFU/mL) with 100% specificity against non-target carbapenemase genes. Clinical validation using 24 urine samples (20 blaKPC-positive, 4 negative) showed 100% concordance with quantitative PCR. In a representative UTI case, TubeCARE enabled 40-min bedside blaKPC detection; early implementation would circumvent 72-h diagnostic delays, facilitating timely carbapenem avoidance and preventing bloodstream complications. Featuring integrated lab-in-a-tube operation, cost-effective manufacturing, user-friendly workflow, and laboratory-grade accuracy, TubeCARE provides actionable antimicrobial resistance surveillance in diverse clinical and resource-limited settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsKlebsiella pneumoniaebeta-LactamasesBacterial ProteinsPoint-of-Care SystemsHumansKlebsiella InfectionsNucleic Acid Amplification TechniquesCRISPR-Cas Systems

Stichwörter der Autor:innen

Real-time fluorescence interpretationSmartphone-assisted detectionCRISPR/Cas12aKPC carbapenemase genePoint-of-care testingUrinary tract infection

Substanzen

beta-LactamasesBacterial Proteinscarbapenemase

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Department of Laboratory Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200127, China.
  • College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Department of Laboratory Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200127, China. rjlimin@shsmu.edu.cn.
  • Department of Laboratory Medicine, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200127, China. renjijywh@shsmu.edu.cn.
  • College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. renjijywh@shsmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Cross-Research Fund of Biomedical Engineering of Shanghai Jiaotong University
  • The Clinical and Excellence Program at the Institute of Molecular Medicine, Shanghai Jiao Tong University School of Medicine

Zitieren

APA

Yang, S., Liu, Y., Zhang, J., Xu, J., Li, T., Huang, H., Zhu, Z., Li, M., Wang, H., & Yang, C. (2025). An integrated lab-in-a-tube platform for point-of-care detection of blaKPC in urinary tract infections. Microchimica Acta. https://doi.org/10.1007/s00604-025-07616-w

Vancouver

Yang S, Liu Y, Zhang J, Xu J, Li T, Huang H, et al. An integrated lab-in-a-tube platform for point-of-care detection of blaKPC in urinary tract infections. Microchimica Acta. 2025. doi:10.1007/s00604-025-07616-w

BibTeX
@article{Yang2025,
  author = {Yang, Shuang and Liu, Yu and Zhang, Junheng and Xu, Jingsong and Li, Tianming and Huang, Haiqian and Zhu, Ziyue and Li, Min and Wang, Hua and Yang, Cuixia},
  title = {An integrated lab-in-a-tube platform for point-of-care detection of blaKPC in urinary tract infections},
  journal = {Microchimica Acta},
  year = {2025},
  doi = {10.1007/s00604-025-07616-w}
}
Kostenlos starten →